JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms (Q58455631)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

J Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Z Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

L Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

R P Gale

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

A V Jones

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

T Qin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

X Ai

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

J Xu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

T Zhang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

X Sun

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Q Li

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

P Zhang

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Y Zhang

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Z Xiao

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

22 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

1763-1767

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337930%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2013.21

22 February 2020

exact match

0 references

cites work

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

The role of mutations in epigenetic regulators in myeloid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

Unique features of primary myelofibrosis in Chinese

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

Concordance of assays designed for the quantification of JAK2V617F: a multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021

JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.21

7 January 2021